A prospective, randomized, placebo‐controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Ng Ernest H.Y.   Lee Sharon W.H.   Ho Pak Chung  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2315-2318

Oxford University Press

Access to resources Recommend Favorite

A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation

By Hamoda Haitham   Ashok Premila W.   Flett Gillian M.M.   Templeton Allan  

Human Reproduction, Vol. 20, Iss. 8, 2005-08 ,pp. : 2348-2354

Oxford University Press

Access to resources Recommend Favorite

The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13–22 weeks gestation

By Fiala C.   Swahn M.L.   Stephansson O.   Gemzell-Danielsson K.  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3072-3077

Oxford University Press

Access to resources Recommend Favorite

A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol

By Tang OS  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 722-725

Oxford University Press

Access to resources Recommend Favorite

Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation

By Tang Oi Shan  

Human Reproduction, Vol. 17, Iss. 7, 2002-07 ,pp. : 1738-1740

Oxford University Press

Access to resources Recommend Favorite